[go: up one dir, main page]

WO2012158127A3 - Water-soluble formulations comprising dexketoprofen - Google Patents

Water-soluble formulations comprising dexketoprofen Download PDF

Info

Publication number
WO2012158127A3
WO2012158127A3 PCT/TR2012/000085 TR2012000085W WO2012158127A3 WO 2012158127 A3 WO2012158127 A3 WO 2012158127A3 TR 2012000085 W TR2012000085 W TR 2012000085W WO 2012158127 A3 WO2012158127 A3 WO 2012158127A3
Authority
WO
WIPO (PCT)
Prior art keywords
dexketoprofen
water
soluble formulations
formulations
soluble
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/TR2012/000085
Other languages
French (fr)
Other versions
WO2012158127A2 (en
Inventor
Mahmut Bilgic
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to EP12730283.4A priority Critical patent/EP2709587A2/en
Publication of WO2012158127A2 publication Critical patent/WO2012158127A2/en
Publication of WO2012158127A3 publication Critical patent/WO2012158127A3/en
Priority to US13/933,323 priority patent/US9717692B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention relates to water-soluble formulations comprising the active agent dexketoprofen and to a process for production of said formulations.
PCT/TR2012/000085 2011-05-18 2012-05-08 Water-soluble formulations comprising dexketoprofen Ceased WO2012158127A2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
EP12730283.4A EP2709587A2 (en) 2011-05-18 2012-05-08 Water-soluble formulations comprising dexketoprofen
US13/933,323 US9717692B2 (en) 2011-05-18 2013-07-02 Effervescent formulations comprising dexketoprofen

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
TR2011/04864A TR201104864A2 (en) 2011-05-18 2011-05-18 Water-soluble formulations containing dexketoprofen.
TR2011/04864 2011-05-18

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
PCT/TR2012/000083 Continuation-In-Part WO2013006146A1 (en) 2011-05-18 2012-05-14 Effervescent formulations comprising dexketoprofen

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US13/933,323 Continuation-In-Part US9717692B2 (en) 2011-05-18 2013-07-02 Effervescent formulations comprising dexketoprofen

Publications (2)

Publication Number Publication Date
WO2012158127A2 WO2012158127A2 (en) 2012-11-22
WO2012158127A3 true WO2012158127A3 (en) 2013-03-07

Family

ID=46395683

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/TR2012/000085 Ceased WO2012158127A2 (en) 2011-05-18 2012-05-08 Water-soluble formulations comprising dexketoprofen

Country Status (3)

Country Link
EP (1) EP2709587A2 (en)
TR (1) TR201104864A2 (en)
WO (1) WO2012158127A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013095315A1 (en) * 2011-12-19 2013-06-27 Mahmut Bilgic Formulations comprising dexketoprofen (particle size 300-2500 micrometer)
TR201723035A2 (en) * 2017-12-29 2019-07-22 Neutec Ar Ge Sanayi Ve Ticaret Anonim Sirketi Dexketoprofen delayed release composition.

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0668851A1 (en) * 1992-11-10 1995-08-30 Menarini Lab ARYLPROPIONIC ACID DERIVATIVE, METHOD FOR THE PRODUCTION THEREOF AND ITS USE AS AN ANALGETIC.
WO2002098388A2 (en) * 2001-06-07 2002-12-12 The Boots Company Plc Effervescent formulations of non-steroidal anti-inflammatory drugs

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4868214A (en) 1987-11-17 1989-09-19 Analgesic Associates Onset-hastened/enhanced analgesia

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0668851A1 (en) * 1992-11-10 1995-08-30 Menarini Lab ARYLPROPIONIC ACID DERIVATIVE, METHOD FOR THE PRODUCTION THEREOF AND ITS USE AS AN ANALGETIC.
WO2002098388A2 (en) * 2001-06-07 2002-12-12 The Boots Company Plc Effervescent formulations of non-steroidal anti-inflammatory drugs

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
ANONYMOUS: "DEXMOL", INTERNET CITATION, 20 December 2010 (2010-12-20), XP055042987, Retrieved from the Internet <URL:http://www.iegm.gov.tr/Folders/KubKT/Yeni%20%C4%B0la%C3%A7%20%C5%9Eube%20M%C3%BCd%C3%BCrl%C3%BC%C4%9F%C3%BC/2010.12.20_Dexmol%2025%20mg%20KUB_209e441.pdf> [retrieved on 20121102] *

Also Published As

Publication number Publication date
EP2709587A2 (en) 2014-03-26
TR201104864A2 (en) 2012-12-21
WO2012158127A2 (en) 2012-11-22

Similar Documents

Publication Publication Date Title
WO2011130615A3 (en) Preparation of lacosamide
WO2012061607A3 (en) Compositions comprising functionalized carbon-based nanostructures and related methods
WO2012084126A3 (en) Formulation of lacosamide
WO2013177419A3 (en) Lipid nanoparticle compositions and methods of making and methods of using the same
WO2014014835A8 (en) Crystalline forms of the prolyl hydroxylase inhibitor [(4-hydroxy-1-methyl-7-phenoxy-isoquinoline-3-carbonyl)-amino]-acetic acid
WO2012129341A3 (en) Disease detection in plants
IL227699A0 (en) Compositions comprising peroxy alpha-ketocarboxylic acid and methods for producing and using the same
WO2012156998A3 (en) Amorphous mirabegron and processes for crystal forms of mirabegron
WO2011093832A3 (en) Stable efervescent formulations comprising cefaclor
WO2014041560A3 (en) Process for the preparation of teneligliptin
MX2014010433A (en) Novel crystalline form of sitagliptin sulfate.
EP3070172A4 (en) Method for manufacturing 3-hydroxybutyric acid using halomonas sp.
WO2013164839A3 (en) Amorphous form of apixaban, process of preparation and compositions thereof
WO2012163937A3 (en) Solid solutions of polyphenols
PL2901857T3 (en) Process for the preparation of 3-chloro-4,5,6-trifluoro-picolinonitrile
WO2012106016A3 (en) Oral care compositions
WO2013155338A3 (en) Substituted benzamides and their uses
ZA201404826B (en) Acamprosate formulations, methods of using the same, and combinations comprising the same
WO2014155389A3 (en) Process for preparation of ticagrelor
IL228462B (en) Film-forming composition for a ph-dependent sustained release of the active agent
EP2672985A1 (en) Citrate free pharmaceutical compositions comprising anakinra
WO2012158127A3 (en) Water-soluble formulations comprising dexketoprofen
WO2011093831A3 (en) Effervescent formulations comprising cefprozil as active agent
WO2014030173A3 (en) Improved process for preparation of atazanavir bisulfate
PL2734492T3 (en) Process for the preparation of 1, 1, 1 - trifluoropropane

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 12730283

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2012730283

Country of ref document: EP